Rachel Brem, Fractional Chief Medical Officer of Feminai, shared on LinkedIn:
“After 25 deeply meaningful years leading the Breast Imaging and Interventional Center at George Washington University, I have paused my clinical practice and left the GW Medical Faculty Associates/Capital Medical Group to begin a new chapter.
While testifying before Congress in support of the EARLY Act – which funds education for young and underserved women about breast health – it became acutely clear to me that education alone is not enough.
We urgently need technologies that can detect breast cancer in women under 40.
Breast cancer diagnoses among women aged 40 and younger have increased by 70% since 2000, yet average-risk women in this age group have no routine screening option. This is an unacceptable gap, and one I am determined to help close.
This is also what fuels my passion and work at the Brem Foundation to defeat breast cancer.
I have therefore taken on the fractional Chief Medical Officer roles with several exciting and innovative technology companies.
My focus will be on advancing new approaches to breast cancer risk assessment, screening, and early detection – for all women, but especially for younger women who are not adequately served by our current screening paradigm.
I am profoundly grateful to my patients for the extraordinary privilege of caring for them. They have taught me so much and have shown me, time and again, the urgent need for better ways to detect breast cancer earlier and save more lives. I also want my patients to know that the incredible team at GW remains there to care for them with the compassion, expertise, and highest level of care they deserve.
‘Early detection saves lives.’
I am profoundly grateful for my years of caring for patients, teaching the next generation, and working alongside extraordinary colleagues.
I now look forward to bringing that experience to the development of critically needed technologies that can change – and save – women’s lives.
This is not a departure from my life’s work. It is the next chapter of it.”
You can also read: Mammo 2026: Global Breast Cancer Leaders to Meet for Two-Day Virtual Congress
